There's only one stock millennials prefer over Amazon and Tesla - MarketWatch
3 Great Stocks for Low-Risk Investors | Nasdaq
Tech stocks soar in 2020 amid pandemic as Seattle-area companies see valuations spike - GeekWire
3 Stocks to Buy in The Coronavirus-Fueled Market Crash | Nasdaq
First to $1 trillion: Amazon or Apple? No-brainer — the people have spoken - MarketWatch
Amazon Stock Can Hit $3,500, Says Analyst. It's a Second-Wave Play. | Barron's
Amazon stock hits $2,000, and why one analyst thinks it is on the road to a $2.5 trillion valuation - GeekWire
Peak Amazon (AMZN)? Not A Chance | Seeking Alpha
Microsoft becomes 2nd-most valuable U.S. company as Amazon slips in wild week on Wall Street - GeekWire
Amazon was almost worth $1 trillion, but it is down $119 billion in just two trading sessions - MarketWatch
Should You Buy ACADIA Pharmaceuticals Stock At $22? | Nasdaq
Roku Is $60 Billion of Amazon Defiance
Big boys of India's pharmaceutical industry may reshape Indian e-pharma - The Economic Times
AI investing: A robot tried to fix value investing and ended up buying Amazon - The Economic Times
Amazon, Microsoft, Alphabet market cap gains add up to a new IBM | Financial Times
Amazon: Amazon reveals scorching India growth as Walmart fight deepens - The Economic Times
3 Pharma Stocks Goldman Sachs Sees as Buys - TheStreet
mid cap pharma stocks News and Updates from The Economic Times - Page 1
Amazon's Prime-Day Change Is a Caution Flag Amid Profit Win
Amazon.com: Biopharma R&D Partnerships: From David & Goliath to Networked R&D (9780993518133): Thong, Robert: Books
reliance industries: Amazon eyes a big pharmacy bet to take on Reliance, Tata Group - The Economic Times
Stock market rally: Amazon, Microsoft, other Seattle companies bounce back from March lows - GeekWire
